Cartesian Therapeutics, Inc.
NASDAQ:RNACBiotechnology
Healthcare
$6.12 -4.15%
-$0.41 today
- Market cap
- $186.68M
- Beta
- 0.78
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$5.65
52W Low $5.60High $15.57
Volume 0.23M
Average 0.26M
Price history
Cartesian Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-19.69%
Period high
$10.59
Period low
$5.84
Latest
$6.12
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Sep 29, 2026 | Sep 29, 2026 | |
| SC 13G | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G/A | Jul 22, 2026 | Jul 22, 2026 | |
| 8-K | Jun 17, 2026 | Jun 17, 2026 | |
| 8-K | Jun 9, 2026 | Jun 9, 2026 | |
| 8-K | May 26, 2026 | May 26, 2026 | |
| SC 13G/A | May 6, 2026 | May 6, 2026 | |
| S-8 | Apr 30, 2026 | Apr 30, 2026 | |
| 10-Q | Apr 30, 2026 | Apr 30, 2026 | |
| 8-K | Apr 30, 2026 | Apr 30, 2026 |
Competitors
Who does Cartesian Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about RNAC's filings, answered from its disclosures.
What is the latest RNAC filing?
The latest filing shown is SC 13G/A dated Nov 6, 2026.
How many recent filings does RNAC have?
Intrinsic Alpha currently shows 20 recent filings for RNAC.
Continue the stock analysis
Jump to another research area for this company.